DUBLIN, Oct. 20, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/3mgjjw/2016_emerging) has announced the addition of the "2016 Emerging Opportunities in the US Immunoprotein Diagnostic Testing Market: Hospitals, Commercial Labs, Physician Offices--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering.
This new 236-page report provides analysis of the US immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
During the next five years, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
The report provides test volume and sales forecasts by market segment for the follow assays:
- Abbott Laboratories
- Agilent Technologies
- Bayer Healthcare
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- Instrumentation Laboratory
- Kyowa Medex
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Thermo Fisher
For more information visit http://www.researchandmarkets.com/research/3mgjjw/2016_emerging
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets